top of page

My take from using Fiasp®

Dr. Matthew Stephen is one my endocrine practice partners. Matt has lived well with type 1 diabetes for 33 years. He has used Fiasp and wrote this summary of his thoughts.

Not surprisingly, the Fiasp® FlexTouch pen looks and feels much like the Tresiba® FlexTouch.

In my limited experience so far with Fiasp, I have appreciated its rapid absorption and action. Pre-meal dosing should be done with caution especially if pre-meal glucose is low or low-normal as it is absorbed and acts noticeably more rapid than other bolus insulins.

I am not in the habit of eating a lot of simple carbohydrate meals or snacks; however, I did find it helpful in staying ahead of glucose rises with both cereal and donut intake.

Further, I found that using it in conjunction with a continuous meter device I was able to wait until there was a faint rising trend (reverse "waiting for the bend") before giving my meal time injection and still limit glucose excursion and peak.

With more experience and practice, I definitely can see potential benefits of Fiasp including flexibility for meal time dosing/time, prompter correction of high glucoses, and improved management of more complex meals.

Hopefully, Fiasp will get pediatric indication and greater insurance coverages very soon.

Featured Posts
Recent Posts
Search By Tags
Follow Us
bottom of page